Sessão Clínica - 29/05/2026
Artigo Científico
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
Apresentador:
Gabriella Bittencourt (R2)
Institucional
Assistência
Ensino
Pesquisa
Extensão
Telemedicina
Artigos da Sessão Clínica
- 29/05/2026 - Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
- 14/05/2026 - Long-term risk of death after tuberculosis diagnosis and treatment
- 08/05/2026 - Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease
- 24/04/2026 - Definition and assessment of high risk in patients considered for lobectomy for stage I non–small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document
- 10/04/2026 - The Impact of Dual Cannabis and Tobacco Smoking in Young Patients With Lung CancerThe Impact of Dual Cannabis and Tobacco Smoking in Young Patients With Lung Cancer
Instituto de Doenças do Tórax - UFRJ
Rua Professor Rodolpho Paulo Rocco, 255, 1º andar, Sala 01D 58/60 – Rio de Janeiro – RJ – CEP 21941-913
Tel: (21) 3938-2887
CNPJ: 33.663.683/0028-36
Destaques
| UFRJ | IDT - Instituto de Doenças do Torax |
| Desenvolvido por: |  |